BTG Pactual Asset Management US’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-262
Closed -$85.8K 337
2025
Q4
$85.8K Buy
+262
New +$83.1K 0.01% 239

Other funds holding AMGN

BTG Pactual Asset Management US's AMGN Position: Q1 2026 in Review

BTG Pactual Asset Management US sold out of Amgen (AMGN) in Q1 2026, closing a stake of 262 shares — an estimated $85.8K sold.

BTG Pactual Asset Management US first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $85.8K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • BTG Pactual Asset Management US reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • BTG Pactual Asset Management US sold 262 Amgen shares in Q1 2026, an estimated $85.8K.
  • BTG Pactual Asset Management US first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
  • BTG Pactual Asset Management US's Amgen position peaked at $85.8K in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on BTG Pactual Asset Management US's 13F filing for Q1 2026, filed 14 May 2026.